|
|
|
|
|
|
|
|
|
|
|
|
|
20.08.26 - 00:54
|
Markets Rebound as Treasury Moves to Rein In Yields | The Close 8/19/2026 (Bloomberg)
|
|
|
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are JPMorgan Private Bank Head of Alternative Investment Strategy Sitara Sundar, Ramp Co-Founder & Co-CEO Eric Glyman, D.A. Davidson Managing Director Senior Research Analyst Michael Baker, The Estée Lauder Companies President & CEO Stéphane de La Faverie, Neuberger Senior Portfolio Manager Eli Salzmann, PGIM Public & Private Fixed Income Co-Chief Investment Officer Gregory Peters, Gravis Robotics CEO & Co-Founder Ryan Luke Johns, Former Walgreens Boots Alliance CEO Roz Brewer, & LSEG Consumer Research Director Jharrone Martis. (Source: Bloomberg)...
|
|
|
|
|
19.08.26 - 22:18
|
Estée Lauder CEO Says Company Has ′Great Momentum′ (Bloomberg)
|
|
|
Estée Lauder Cos. Chief Executive Officer Stéphane de La Faverie says the company is expanding margin and has great momentum going forward. The beauty and makeup giant reported revenue and earnings for the fiscal fourth quarter that topped estimates. He speaks on "Bloomberg The Close." (Source: Bloomberg)...
|
|
|
|
|
|
|
19.08.26 - 17:54
|
Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers (Bloomberg)
|
|
|
On this episode of Stock Movers:
- Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday.
- Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views.
- Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
19.08.26 - 14:42
|
Starke Nachfrage nach Luxus-Kosmetik beflügelt Aktie von Estee Lauder (Cash)
|
|
|
Die Aktie des New Yorker Unternehmens legte am Mittwoch im vorbörslichen Handel an der Wall Street um fast acht Prozent zu. Für das Geschäftsjahr 2027 rechne der Eigentümer von Marken wie Clinique und M.A.C mit einem bereinigten Gewinn je Aktie zwischen 3,10 und 3,35 Dollar und liegt damit über den Markterwartungen, wie der vor rund 120 Jahren gegründete Konzern mitteilte. Zudem übertraf der Umsatz im abgelaufenen vierten Quartal mit 3,63 Milliarden Dollar die Erwartungen von 3,54 Milliarden Dollar...
|
|
|
|
|
|
|
|
|
|